Skip to main content
Erschienen in: Herz 8/2015

01.12.2015 | Schwerpunkt

ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes

Was ist neu?

verfasst von: T. Fink, Prof. Dr. K.H. Kuck, PD Dr. A. Metzner

Erschienen in: Herz | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die auf der diesjährigen Jahrestagung der European Society of Cardiology (ESC) in London vorgestellten Leitlinien zur Therapie von Patienten mit ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes umfassen eine umfangreiche Aktualisierung der Empfehlungen zur Diagnostik sowie zur medikamentösen, interventionellen und Device-gestützten Therapie ventrikulärer Tachyarrhythmien. Die bereits vorhandenen Leitlinien zur primär- und sekundärprophylaktischen ICD (implantierbarer Kardioverter-Defibrillator)-Implantation wurden punktuell erweitert. Die Empfehlungen zur Katheterablation ventrikulärer Tachykardien wurden aktualisiert und, der zunehmenden Datenlage Rechnung tragend, ausgeweitet. Hinsichtlich Diagnostik und Therapie hereditärer Arrhythmien erfolgte größtenteils eine Angleichung an den 2013 publizierten Konsensusreport der Expertenkommission der American Heart Association (AHA), der European Heart Rhythm Association (EHRA) und der Asia Pacific Heart Rhythm Society (APHRS).
Literatur
1.
Zurück zum Zitat Priori SG et al (2015) ESC 2015 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace [Epub ahead of print] Priori SG et al (2015) ESC 2015 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Europace [Epub ahead of print]
2.
Zurück zum Zitat Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com. J Am Coll Cardiol 48(5):e247–e346CrossRefPubMed Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M et al (2006) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Com. J Am Coll Cardiol 48(5):e247–e346CrossRefPubMed
3.
Zurück zum Zitat Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T et al (2014) EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 16(9):1257–1283CrossRefPubMed Pedersen CT, Kay GN, Kalman J, Borggrefe M, Della-Bella P, Dickfeld T et al (2014) EHRA/HRS/APHRS expert consensus on ventricular arrhythmias. Europace 16(9):1257–1283CrossRefPubMed
4.
Zurück zum Zitat Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1–e62CrossRefPubMed Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, Freedman RA, Gettes LS et al (2008) ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 51(21):e1–e62CrossRefPubMed
5.
Zurück zum Zitat Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NAM et al (2012) ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61(3):e6–e75.CrossRefPubMed Tracy CM, Epstein AE, Darbar D, Dimarco JP, Dunbar SB, Estes NAM et al (2012) ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 61(3):e6–e75.CrossRefPubMed
6.
Zurück zum Zitat Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 34(29):2281–2329CrossRefPubMed Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt O-A et al (2013) ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 34(29):2281–2329CrossRefPubMed
7.
Zurück zum Zitat Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10(12):1932–1963CrossRefPubMed Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C et al (2013) HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm 10(12):1932–1963CrossRefPubMed
8.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128(16):e240–e327CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH et al (2013) ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 128(16):e240–e327CrossRefPubMed
9.
Zurück zum Zitat Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR et al (2014) HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 130:94–125CrossRefPubMed Kusumoto FM, Calkins H, Boehmer J, Buxton AE, Chung MK, Gold MR et al (2014) HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation 130:94–125CrossRefPubMed
10.
Zurück zum Zitat Basso C, Burke M, Fornes P, Gallagher PJ, De Gouveia RH, Sheppard M et al (2008) Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 452(1):11–18CrossRefPubMed Basso C, Burke M, Fornes P, Gallagher PJ, De Gouveia RH, Sheppard M et al (2008) Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch 452(1):11–18CrossRefPubMed
11.
Zurück zum Zitat Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al (1997) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940CrossRef Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H et al (1997) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 335:1933–1940CrossRef
12.
Zurück zum Zitat Bigger TJ (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337:1569–1575CrossRefPubMed Bigger TJ (1997) Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337:1569–1575CrossRefPubMed
13.
Zurück zum Zitat Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890CrossRefPubMed Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G (1999) A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 341:1882–1890CrossRefPubMed
14.
Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRefPubMed Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346(12):877–883CrossRefPubMed
15.
Zurück zum Zitat Bardy GH, Lee KL, Mark DB, Poole JE, Packer D, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237CrossRefPubMed Bardy GH, Lee KL, Mark DB, Poole JE, Packer D, Boineau R et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352(3):225–237CrossRefPubMed
16.
Zurück zum Zitat Desai A, Fang JC, Maisel WH, Baughman KL (2004) Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292(23):2874–2879CrossRefPubMed Desai A, Fang JC, Maisel WH, Baughman KL (2004) Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA 292(23):2874–2879CrossRefPubMed
17.
Zurück zum Zitat Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105(12):1453–1458CrossRefPubMed Bänsch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K et al (2002) Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105(12):1453–1458CrossRefPubMed
18.
Zurück zum Zitat Krueger S, Kass DA, Marco T De, Carson P, Dicarlo L, Demets D et al (2009) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150 Krueger S, Kass DA, Marco T De, Carson P, Dicarlo L, Demets D et al (2009) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350(21):2140–2150
19.
Zurück zum Zitat Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158CrossRefPubMed Kadish A, Dyer A, Daubert JP, Quigg R, Estes NAM, Anderson KP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350(21):2151–2158CrossRefPubMed
20.
Zurück zum Zitat Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 41(10):1707–1712CrossRefPubMed Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL et al (2003) Amiodarone versus implantable cardioverter-defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia – AMIOVIRT. J Am Coll Cardiol 41(10):1707–1712CrossRefPubMed
21.
Zurück zum Zitat Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21(24):2071–2078CrossRefPubMed Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al (2000) Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 21(24):2071–2078CrossRefPubMed
22.
Zurück zum Zitat Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO et al (1999) Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation 99(13):1692–1699CrossRefPubMed Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora MO et al (1999) Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators. Circulation 99(13):1692–1699CrossRefPubMed
23.
Zurück zum Zitat Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102(7):748–754CrossRefPubMed Kuck KH, Cappato R, Siebels J, Rüppel R (2000) Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation 102(7):748–754CrossRefPubMed
24.
Zurück zum Zitat Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101(11):1297–1302CrossRefPubMed Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS et al (2000) Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101(11):1297–1302CrossRefPubMed
25.
Zurück zum Zitat Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et al (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944–953CrossRefPubMed Weiss R, Knight BP, Gold MR, Leon AR, Herre JM, Hood M et al (2013) Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator. Circulation 128(9):944–953CrossRefPubMed
26.
Zurück zum Zitat Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M et al (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythmia Electrophysiol 5(5):913–919CrossRef Aydin A, Hartel F, Schlüter M, Butter C, Köbe J, Seifert M et al (2012) Shock efficacy of subcutaneous implantable cardioverter-defibrillator for prevention of sudden cardiac death: initial multicenter experience. Circ Arrhythmia Electrophysiol 5(5):913–919CrossRef
27.
Zurück zum Zitat Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L et al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363(1):36–44CrossRefPubMed Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L et al (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363(1):36–44CrossRefPubMed
28.
Zurück zum Zitat Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA et al (2015) Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol 65(16):1605–1615CrossRefPubMed Burke MC, Gold MR, Knight BP, Barr CS, Theuns DAMJ, Boersma LVA et al (2015) Safety and efficacy of the totally subcutaneous implantable defibrillator. J Am Coll Cardiol 65(16):1605–1615CrossRefPubMed
29.
Zurück zum Zitat Jarman JWE, Lascelles K, Wong T, Markides V, Clague JR, Till J (2012) Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 33(11):1351–1359CrossRefPubMed Jarman JWE, Lascelles K, Wong T, Markides V, Clague JR, Till J (2012) Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 33(11):1351–1359CrossRefPubMed
30.
Zurück zum Zitat Jarman JWE, Todd DM (2013) United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 15(8):1158–1165CrossRefPubMed Jarman JWE, Todd DM (2013) United Kingdom national experience of entirely subcutaneous implantable cardioverter-defibrillator technology: important lessons to learn. Europace 15(8):1158–1165CrossRefPubMed
31.
Zurück zum Zitat Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S et al (2013) Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Hear Rhythm 10(1):29–36CrossRef Köbe J, Reinke F, Meyer C, Shin DI, Martens E, Kääb S et al (2013) Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. Hear Rhythm 10(1):29–36CrossRef
32.
Zurück zum Zitat Lambiase PD, Barr C, Theuns DAMJ, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J 35(25):1657–1665PubMedCentralCrossRefPubMed Lambiase PD, Barr C, Theuns DAMJ, Knops R, Neuzil P, Johansen JB et al (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD registry. Eur Heart J 35(25):1657–1665PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Olde Nordkamp LRA, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS et al (2012) Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 163(5):753–760.e2CrossRefPubMed Olde Nordkamp LRA, Knops RE, Bardy GH, Blaauw Y, Boersma LVA, Bos JS et al (2012) Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J 163(5):753–760.e2CrossRefPubMed
34.
Zurück zum Zitat Auricchio A, Klein H, Geller CJ, Reek S, Heilman MS, Szymkiewicz SJ (1998) Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol 81(10):1253–1256CrossRefPubMed Auricchio A, Klein H, Geller CJ, Reek S, Heilman MS, Szymkiewicz SJ (1998) Clinical efficacy of the wearable cardioverter-defibrillator in acutely terminating episodes of ventricular fibrillation. Am J Cardiol 81(10):1253–1256CrossRefPubMed
35.
Zurück zum Zitat Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 56(3):194–203PubMedCentralCrossRefPubMed Chung MK, Szymkiewicz SJ, Shao M, Zishiri E, Niebauer MJ, Lindsay BD et al (2010) Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol 56(3):194–203PubMedCentralCrossRefPubMed
36.
Zurück zum Zitat Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV et al (2013) Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 62(21):2000–2007CrossRefPubMed Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV et al (2013) Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol 62(21):2000–2007CrossRefPubMed
37.
Zurück zum Zitat Kao AC, Krause SW, Handa R, Karia D, Reyes G, Bianco NR et al (2012) Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord 12(1):123PubMedCentralCrossRefPubMed Kao AC, Krause SW, Handa R, Karia D, Reyes G, Bianco NR et al (2012) Wearable defibrillator use in heart failure (WIF): results of a prospective registry. BMC Cardiovasc Disord 12(1):123PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657–2665PubMedCentralCrossRefPubMed Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K et al (2007) Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 357(26):2657–2665PubMedCentralCrossRefPubMed
39.
Zurück zum Zitat Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM et al (2000) Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter. J Am Coll Cardiol 35(7):1905–1914CrossRefPubMed Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM et al (2000) Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: results of a prospective multicenter. J Am Coll Cardiol 35(7):1905–1914CrossRefPubMed
40.
Zurück zum Zitat Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T et al (2008) Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118(25):2773–2782CrossRefPubMed Stevenson WG, Wilber DJ, Natale A, Jackman WM, Marchlinski FE, Talbert T et al (2008) Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction the multicenter thermocool ventricular tachycardia ablation trial. Circulation 118(25):2773–2782CrossRefPubMed
41.
Zurück zum Zitat Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D et al (2010) Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 21(1):47–53CrossRefPubMed Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D et al (2010) Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol 21(1):47–53CrossRefPubMed
42.
Zurück zum Zitat Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31–40CrossRefPubMed Kuck K-H, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrétaz E et al (2010) Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial. Lancet 375(9708):31–40CrossRefPubMed
43.
Zurück zum Zitat Waldo AL (2007) Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. Yearb Cardiol 2007(2):450–451CrossRef Waldo AL (2007) Comparison of β-blockers, amiodarone plus β-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial. Yearb Cardiol 2007(2):450–451CrossRef
44.
Zurück zum Zitat Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C et al (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129(7):728–736CrossRefPubMed Dinov B, Fiedler L, Schönbauer R, Bollmann A, Rolf S, Piorkowski C et al (2014) Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study. Circulation 129(7):728–736CrossRefPubMed
45.
Zurück zum Zitat Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117(4):462–469CrossRefPubMed Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G et al (2008) Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation 117(4):462–469CrossRefPubMed
46.
Zurück zum Zitat Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C et al (2010) Relationship between burden of premature ventricular complexes and left ventricular function. Hear Rhythm 7(7):865–869CrossRef Baman TS, Lange DC, Ilg KJ, Gupta SK, Liu TY, Alguire C et al (2010) Relationship between burden of premature ventricular complexes and left ventricular function. Hear Rhythm 7(7):865–869CrossRef
47.
Zurück zum Zitat Deyell MW, Park KM, Han Y, Frankel DS, Dixit S, Cooper JM et al (2012) Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Hear Rhythm 9(9):1465–1472CrossRef Deyell MW, Park KM, Han Y, Frankel DS, Dixit S, Cooper JM et al (2012) Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations. Hear Rhythm 9(9):1465–1472CrossRef
Metadaten
Titel
ESC-Leitlinien 2015 zu ventrikulären Arrhythmien und zur Prävention des plötzlichen Herztodes
Was ist neu?
verfasst von
T. Fink
Prof. Dr. K.H. Kuck
PD Dr. A. Metzner
Publikationsdatum
01.12.2015
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 8/2015
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-015-4380-6

Weitere Artikel der Ausgabe 8/2015

Herz 8/2015 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.